Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker APUS
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Oct 13, 2026 | APUS Apimeds Pharmaceuticals US, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 1, 2026 | APUS Apimeds Pharmaceuticals US, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Sep 29, 2026 | APUS Apimeds Pharmaceuticals US, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Sep 23, 2026 | APUS Apimeds Pharmaceuticals US, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Sep 23, 2026 | APUS Apimeds Pharmaceuticals US, Inc. | 3.03 Material Modification to Rights of Security Holders | 8-K | 8-K ↗ |
| Sep 11, 2026 | APUS Apimeds Pharmaceuticals US, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Sep 11, 2026 | APUS Apimeds Pharmaceuticals US, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Aug 21, 2026 | APUS Apimeds Pharmaceuticals US, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Aug 6, 2026 | APUS Apimeds Pharmaceuticals US, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jul 13, 2026 | APUS Apimeds Pharmaceuticals US, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 5, 2026 | APUS Apimeds Pharmaceuticals US, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 4, 2026 | APUS Apimeds Pharmaceuticals US, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 4, 2026 | APUS Apimeds Pharmaceuticals US, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 4, 2026 | APUS Apimeds Pharmaceuticals US, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Apr 22, 2026 | APUS Apimeds Pharmaceuticals US, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Apr 16, 2026 | APUS Apimeds Pharmaceuticals US, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Apr 9, 2026 | APUS Apimeds Pharmaceuticals US, Inc. | 8.01 Other Events | 8-K/A | 8-K ↗ |
| Apr 9, 2026 | APUS Apimeds Pharmaceuticals US, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K/A | 8-K ↗ |
| Apr 9, 2026 | APUS Apimeds Pharmaceuticals US, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K/A | 8-K ↗ |
| Mar 26, 2026 | APUS Apimeds Pharmaceuticals US, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 26, 2026 | APUS Apimeds Pharmaceuticals US, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Mar 26, 2026 | APUS Apimeds Pharmaceuticals US, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Mar 25, 2026 | APUS Apimeds Pharmaceuticals US, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 25, 2026 | APUS Apimeds Pharmaceuticals US, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Mar 25, 2026 | APUS Apimeds Pharmaceuticals US, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Mar 16, 2026 | APUS Apimeds Pharmaceuticals US, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 17, 2026 | APUS Apimeds Pharmaceuticals US, Inc. | 2.01 Completion of Acquisition or Disposition of Assets | 8-K/A | 8-K ↗ |
| Jan 2, 2026 | APUS Apimeds Pharmaceuticals US, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Dec 10, 2025 | APUS Apimeds Pharmaceuticals US, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Dec 10, 2025 | APUS Apimeds Pharmaceuticals US, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K/A | 8-K ↗ |
| Dec 10, 2025 | APUS Apimeds Pharmaceuticals US, Inc. | 3.03 Material Modification to Rights of Security Holders | 8-K/A | 8-K ↗ |
| Dec 10, 2025 | APUS Apimeds Pharmaceuticals US, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K/A | 8-K ↗ |
| Dec 2, 2025 | APUS Apimeds Pharmaceuticals US, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 2, 2025 | APUS Apimeds Pharmaceuticals US, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Dec 2, 2025 | APUS Apimeds Pharmaceuticals US, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Dec 2, 2025 | APUS Apimeds Pharmaceuticals US, Inc. | 5.01 Changes in Control of Registrant | 8-K | 8-K ↗ |
| Dec 2, 2025 | APUS Apimeds Pharmaceuticals US, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Dec 2, 2025 | APUS Apimeds Pharmaceuticals US, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Dec 2, 2025 | APUS Apimeds Pharmaceuticals US, Inc. | 2.01 Completion of Acquisition or Disposition of Assets | 8-K | 8-K ↗ |
| Dec 2, 2025 | APUS Apimeds Pharmaceuticals US, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Nov 18, 2025 | APUS Apimeds Pharmaceuticals US, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Oct 16, 2025 | APUS Apimeds Pharmaceuticals US, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Jul 16, 2025 | APUS Apimeds Pharmaceuticals US, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 5, 2025 | APUS Apimeds Pharmaceuticals US, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 20, 2025 | APUS Apimeds Pharmaceuticals US, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| May 12, 2025 | APUS Apimeds Pharmaceuticals US, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 12, 2025 | APUS Apimeds Pharmaceuticals US, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| May 12, 2025 | APUS Apimeds Pharmaceuticals US, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Apr 15, 2025 | APUS Apimeds Pharmaceuticals US, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
49 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:23 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances